Recordati Rare Diseases

At Recordati Rare Diseases, we are dedicated to making a meaningful impact in the lives of people facing rare diseases. This week, we stand together in support of Neuroblastoma Awareness Week, shining a spotlight to bring attention to this rare pediatric cancer. By supporting this awareness day, we emphasize our ongoing commitment in fostering awareness and understanding about Neuroblastoma. Together, we can make a difference and bring light to the journey of children affected by Neuroblastoma. #NeuroblastomaAwarenessDay

🎉 Congratulations to our team of 70 dedicated colleagues who participated in the "Enfants sans Cancer City" charity run, supporting the French patient association Imagine for Margo - Children without Cancer!   By joining forces with Imagine for Margo, we help fund essential research that is crucial in the fight against pediatric cancer, providing hope and better futures for countless children and their families.   Thank you for your commitment and for making a real difference. Together, we can turn the tide against childhood cancer and create a better tomorrow for young patients everywhere.   #ImagineForMargo #EnfantsSansCancerCity #FightingChildhoodCancer 

On World Environment Day we’re delighted to announce that we’re expanding the use of solar power in our plants – continuing our commitment to installing new renewable energy production systems in our manufacturing sites. Following our teams in Spain and Ireland, the Recordati plant in Türkiye is following suit and is now authorised to use its newly completed solar panel system. These solar panels have a maximum power output of around 480 kWp, covering part of the plant's needs. Any further electricity needed for the plant will continue to be purchased from grid, ensuring that it comes from renewable sources. A great example of our sustainability approach through responsible action, protecting our most important assets: people and planet. #WorldEnvironmentDay #Sustainability #PeopleandPlanet

Tomorrow, a dedicated team of 70 colleagues from Recordati Rare Diseases will be participating in the Enfants sans Cancer City charity run in Paris la Défense! We are incredibly proud to support the association Imagine for Margo - Children without Cancer in their efforts to combat pediatric cancer. Their mission resonates deeply with our commitment to making a difference in the world of rare diseases.   We invite you to join us in supporting this incredible cause. Whether you’re running, cheering from the sidelines, every bit helps in the fight against childhood cancers!   For more information about Imagine for Margo and how you can contribute, please visit: https://lnkd.in/gYxFy8T   Let’s make a difference together!   #CharityRun #ImagineForMargo #ChildhoodCancer #RareDiseases #EnfantsSansCancer

Today is World Homocystinuras Awareness Day! Homocystinurias are a group of rare genetic disorders affecting how the body processes methionine, leading to elevated homocysteine levels in the blood. This can result in a range of health complications impacting the eyes, bones, central nervous system and cardiovascular system. On World Homocystinurias Awareness Day, join us in amplifying the voices of those impacted by Homocystinurias and advocating for greater awareness and resources. Together, we can make a meaningful difference in the lives of patients and families affected by these rare disorders. #HomocystinuriasAwarenessDay #RareDiseases #PatientCare #FocusedOnTheFew 

Pleased to announce the winner of the 11th edition of the International Prize for Scientific Research Arrigo Recordati: Adam Durbin, MD PhD. The Prize was established in 2000 in memory of the Italian pharmaceutical entrepreneur Arrigo Recordati to perpetuate his legacy and to inspire biomedical discoveries benefiting people worldwide. Dedicated this year to research in paediatric oncology, specifically neuroblastoma, Dr Durbin’s project was selected from over 40 entries by an independent panel of internationally recognised rare disease experts. The Prize was awarded at the 5th Annual Meeting of the European Society for Paediatric Oncology (SIOP), held in Milan, with Dr Durbin’s project receiving a €100,000 research grant. Click here to read the full press release: https://lnkd.in/evwsqZdk #RareDisease #Innovation #ArrigoRecordatiPrize #Oncology #OncologyResearch

We’re excited to announce that Recordati Rare Diseases will be hosting a symposium at the SIOPE Congress, on Thurday 16 May, from 1 to 2 PM CET in Milan! Intended for healthcare professionals only, join us for an insightful discussion on "Real world clinical practice in refractory and relapsed neuroblastoma," where leading experts will share valuable insights and experiences in tackling this challenging aspect of paediatric oncology. 🗓️ Mark your calendars and don’t miss this opportunity to engage with experts in the field! #SIOPECongress #PaediatricOncology

As the curtains fall on this outstanding ECE edition in Sweden, we express our sincere gratitute to everyone who contributed to its success. 🙌 The opportunity to participate allowed us to connect with international dedicated attendees, fostering valuable conversations and forging meaningful relationships. We are truly thrilled by the connections made and look forward to continued collaboration! Thank you for being part of this incredible journey! 🌐👩⚕️👨⚕️ #ESEndocrinology #ECE2024 #HealthcareInnovation

🌟 Join Our satellite symposium! As an Healthcare Professional, would you like to learn more about the latest news about #CushingsSyndrome and #Acromegaly management? Look no further! Gain expert insights from Drs. Fleseriu, MK Biller, Reincke, and Esposito. 🗓️ When: Monday, 13 May, 12:40 – 13:55 TRT at the congress in the Victoria Hall and streamed live to ECE@Home delegates. #ESEndocrinology #ECE2024 Learn more at eseondemand.org. See you there! 🎉

Today is the opening of the European Congress of Endocrinology (ECE). At RRD we are proud to be part of this event with healthcare professionals. Meet us at our booth n°28! We will also share latest news on #Cushingssyndrome and #Acromegaly during our Satellite Symposium from Monday the 13th! 🔗 Network, Learn, Engage: Let’s ignite conversations. Shape the future. 🌟 #ESEndocrinology #ECE2024